Jim Esquea, VP, Public Affairs, for

The Scotts Miracle-Gro Company Named to Board of Directors Of the Council for Federal Cannabis Regulation (CFCR)

DECEMBER 1, 2021

WASHINGTON, D.C. (December 1, 2021)  – The Scotts Miracle-Gro Company and the Council for Federal Cannabis Regulation (CFCR) jointly announced today that the company’s Vice President of Public Affairs, Jim Esquea, will join the CFCR leadership as a member of their Board of Directors.

 

Esquea brings to this role more than 25 years of policy experience, having previously served as Assistant Secretary for Legislation at the U.S. Department of Health and Human Services in the Obama Administration, as a senior analyst for the U.S. Senate Budget Committee and budget analyst in the Office of Management and Budget in the Clinton Administration. 

 

“On behalf of ScottsMiracle-Gro I’m excited to join CFCR’s leadership team and their mission to assist the government, and its federal regulatory agencies, to rethink, develop, and implement evidence-based cannabis regulations,” said Esquea. “ScottsMiracle-Gro, through its subsidiary The Hawthorne Gardening Company, is a leading provider of nutrients, lighting and other materials used in indoor and hydroponic growing and have unique insights about the emerging cannabis industry. With 37 states having approved cannabis for recreational or medical use, the federal policy dialogue around cannabis will only intensify … and we look forward to contributing to the conversation and working with CFCR.”

 

For CFCR, the connection with Esquea and ScottsMiracle-Gro has natural synergy.

 

“We enthusiastically welcome ScottsMiracle-Gro and Jim Esquea to our ranks,” said Council Founder and Board Chair Sheri Orlowitz.  “Jim is both brilliant and kind; very much CFCR values.   Our mission – to destigmatize, legitimize and normalize cannabis through working as an objective third party with the federal agencies – aligns perfectly with Scotts’ perspective and Jim’s storied career that spans over two decades with the federal government.  Having served as an HHS Assistant Secretary for Legislation, Jim will bring critical insight to our work with federal agencies, a key asset to helping both the FDA and HHS understand and embrace the cannabis industry.

 

 

Named to his position in April of 2021, Esquea is the company’s first position based in Washington, DC. He leads the company’s day-to-day federal outreach on issues that range from cannabis and social justice reform to environmental regulation, consumer protection and corporate tax policies.  He most recently served as the Senior Director of Federal Affairs for Juul Labs Inc. A graduate of Wesleyan University, Esquea also holds an M.P.A. from Columbia University.

 

About CFCR

 

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) non-profit based in Washington, DC. The mission of CFCR is to assist the government, and specifically federal regulatory agencies, to rethink, develop, and implement evidence-based cannabis regulations. Our overarching goal is the de-stigmatization, normalization, and legitimization of cannabis on behalf of consumers, the professions, organizations, and businesses who support and serve them. We do this by serving as a conduit for informed scientific research, inclusive education, and by mainstreaming the best practices that enable the industry to maximize its potential. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

 

 

About ScottsMiracle-Gro

 

With approximately $4.9 billion in sales, the Company is one of the world’s largest marketers of branded consumer products for lawn and garden care. The Company’s brands are among the most recognized in the industry. The Company’s Scotts®, Miracle-Gro® and Ortho® brands are market-leading in their categories. The Company’s wholly owned subsidiary, The Hawthorne Gardening Company, is a leading provider of nutrients, lighting and other materials used in the indoor and hydroponic growing segment. For additional information, visit www.scottsmiraclegro.com.

####

Council for Federal Cannabis Regulation (CFCR) to Offer International Cannabis Regulation Insight in Upcoming November 19 Webinar

NOVEMBER 11, 2021

WASHINGTON, D.C. (November 11, 2021)  – Following the successful launch of its monthly webinar series in September 2021, the Council for Federal Cannabis Regulation (CFCR) today announced “International Cannabis Regulation: Informing a Pathway for the US Agencies” as the topic for November’s virtual conversation. Joining the discussion will be seasoned policy advisor and current Managing Director of the European Industrial Hemp Association (EIHA) Lorenza Romanese, along with Dr. Palmer Orlandi, Deputy Executive Director and Chief Science Officer at AOAC International (formerly known as the Association of Official Analytical Chemists) and Oscar Hackett, CFO and President of Open Book Extracts.  Hosts include CFCR’s own Executive Director Sarah A. Chase and Thompson Coburn LLP Advisor Jack Jacobson. The event is scheduled for Friday, November 19, from 1:00 until 2:00 p.m. EST.

 

With roughly 125 monthly listeners already since debuting September 18th, CFCR has explored various facets of the cannabis industry in their monthly webinar series – including the regulatory impacts of a groundbreaking CBD study, as well as Federal and state cannabis policies. The Council has committed to organizing a webinar on the second or third Thursday of every month (depending on holidays), each to spotlight a wide range of industry professionals and focus on preparing to regulate and regulating today’s legal cannabis molecules and products. The virtual sessions can be viewed on WebEx and will feature a moderator accompanied by two-to-three panelists. Each webinar will consist of a 40-minute interactive conversation followed by approximately 20-minutes of moderated audience Q&A for a total run-time of approximately one hour.

 

Speaker Profiles for the November 19 Webinar:

 

Lorenza Romanese

 

A brilliant strategist and fierce advocate for policy and reform, Lorenza Romanese is the present Managing Director of the European Industrial Hemp Association (EIHA) and has led its efforts in Brussels since early 2019. Romanese has a proven background in communications at the European-level and in suggesting reforms related to hemp in the EU’s Common Agriculture Policy. She previously led the European Association of Independent Winegrowers and specialized in interests in both the gas and oil sectors

Oscar Hackett

 

President and CFO of Open Book Extracts and a graduate of Georgetown and Harvard University Law School, A member of the CFCR Executive Committee, Oscar Hackett is a new venture formation and capitalization expert with multiple start-ups built and exited. Oscar is a strategic CFO and GC with deep fundraising (equity and debt) and regulatory experience.

Palmer A. Orlandi, Jr.

 

Deputy Executive Director and Chief Science Officer at AOAC INTERNATIONAL, Palmer Orlandi, Jr. oversees the AOAC Research Institute, Standards Development Activities, and the Proficiency Testing Program. He also manages business development which includes strategic partnerships with the goal of advancing voluntary consensus standards-setting activities and strengthening international relations.

To register for this CFCR’s webinar series, please visit: https://www.uscfcr.org/events

 

For additional information, please visit uscfcr.org.

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) non-profit based in Washington, DC. The mission of CFCR is to assist the government, and specifically federal regulatory agencies, to rethink cannabis regulations. CFCR’s overarching goal is the de-stigmatization, normalization, and legitimization of cannabis on behalf of consumers, the professions, organizations, and businesses who support and serve them. CFCR does this by serving as a conduit for informed scientific research, inclusive education, and by mainstreaming the best practices that enable the industry to maximize its potential. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.   

Lorenza HS_edited.jpg
1516305607452.jpeg
Palmer-270x300_edited.jpg

Webinar to Examine Critical Federal and State Cannabis Regulation

Next Council for Federal Cannabis Regulation Event Scheduled for

Thursday, October 28, 1:00 EST

OCTOBER 18, 2021

WASHINGTON, D.C. (October 18, 2021)  – The Council for Federal Cannabis Regulation (CFCR) today announced the next webinar in a series of monthly informative sessions titled “Cannabis Regulation: What the Federal Government Can Learn from the States.” It is set to take place on Thursday, October 28, beginning at 1 p.m. EST. The webinar will call upon two experts in the cannabis industry – Dr. Gillian Schauer, Executive Director of Cannabis Regulators Association (CANNRA) and Toi Hutchinson, Senior Advisor to Governor JB Pritzker for Cannabis Control. The discussion will be hosted by Sarah A. Chase, CFCR’s Executive Director, along with Jack Jacobson, Advisor at Thompson Coburn LLP.

 

CFCR launched its virtual webinar series last month with a discussion tackling the regulatory impacts of a groundbreaking CBD study. The Council will continue to host an educational webinar on the second or third Thursday of every month, depending on holidays. The sessions can be viewed over WebEx and will each feature a moderator accompanied by two-to-three panelists. Scheduled to run for approximately one hour, each webinar will consist of a 40-minute interactive conversation followed by approximately 20-minutes of moderated audience Q&A.

 

Speaker Profiles for the October 28 Webinar:

 

Gillian Schauer: Prior to CANNRA’s founding, Gillian Schauer, PhD, MPH served as a Senior Advisor before she was elected the organization’s first Executive Director in 2021. She brings nearly 20 years of experience in public health and policy to the role of Executive Director and has an extensive background in partnering with federal and state agencies on cannabis policy, data monitoring, and research translation. Dr. Schauer also founded the Multi-State Collaborative for Cannabis and Public Health and led its initiatives from 2014 to 2021

 

Toi Hutchinson: A former member of the Illinois State Senate, Toi Hutchinson represented the 40th District from 2009 to 2019 and advocated for causes that include protecting women and children from violence and legalizing cannabis. Hutchinson is an original co-sponsor of the Cannabis Regulation and Tax Act (CRTA), which aims to legalize adult-use cannabis in an equity-centric manner. She was appointed in 2019 to serve as the Senior Advisor to the Governor for Cannabis Control by Illinois Governor J.B. Pritzker.

To register for this CFCR’s webinar series, please visit: https://www.uscfcr.org/events

 

For additional information, please visit uscfcr.org.

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

gillian_schauer_001_lowres_crop_2.jpeg
ToiHutchnson_Picture1.jpg

Council for Federal Cannabis Regulation (CFCR) discusses groundbreaking new cannabis study in cfcr's webinar debut

OCTOBER 1, 2021

WASHINGTON, D.C. – The Council for Federal Cannabis Regulation (CFCR) last Thursday launched its inaugural monthly webinar series in which regulators and industry professionals will participate in moderated conversations regarding responsible cannabis regulation. Last week’s webinar focused on the impact of a groundbreaking CBD study published in the top international peer-reviewed medical journal, JAMA, and, which demonstrated a positive therapeutic effect of CBD with a defined dose in a randomized clinical trial on reduction of anxiety, depression, fatigue in front line health care workers.

 

The webinar featured guest speaker Dr. Vicki Seyfert-Margolis, a former FDA leader and Chairwoman of the Science & Regulatory Affairs Committee for CFCR, along with moderators Jack Jacobson from Thompson Coburn LLP and CFCR’s own Executive Director Sarah Chase.

 

The webinar focused on how the study was conducted, that is, in a hospital, using front line healthcare workers, which made gathering data much easier and more cost effective. The study demonstrated that medically valid “randomized controlled” trials (RCT) can be done with cannabinoids, including clinical assessments for safety and efficacy using such well-known and understood tools as blood tests, and standard medical grade scales for assessments. This study can be a “blueprint” for other cannabinoid researchers to model and provide the science the FDA is seeking.

 

One big takeaway is while close to 5% of the study participants experienced mild to serious elevated liver enzymes, the liver enzymes returned to normal after discontinuation of CBD.

 

The monthly webinar series will continue over WebEx on Thursday, October 28 with a focus on what federal regulators can learn from current state laws, regulations, and the best practices governing cannabis. This webinar will feature panelists from various state legislative offices and current cannabis regulators.

 

View a recording of the Webcast at https://www.uscfcr.org/events

 

For additional information, please visit uscfcr.org.

 

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

Council for Federal Cannabis Regulation (CFCR) Engages Four Diverse Communication Partners to Enhance Brand Awareness Through Strategic Messaging

SEPTEMBER 28, 2021

WASHINGTON, D.C. – The Council for Federal Cannabis Regulation (CFCR) today announced formal partnerships with four communication agencies to develop concise and impactful messaging across several fronts -- including public relations, social media and graphics, creative video and visual content, and web design. Through powerful crafting and delivery of their messaging, CFCR’s intends to maximize its outreach as an advocate for federal regulations in the cannabis industry.

 

Brotman | Winter | Fried (BWF), part of the Sage Communications umbrella, will provide CFCR with public relations and outreach support. Steve Winter, President and COO of BWF, will serve as the driving force behind the development of CFCR’s messaging and the delivery of the council’s various programs and initiates to the public. Winter will also serve as the key messaging strategist on the CFCR Advisory Board. BWF is a PR agency that is well connected with various industries, including sports, entertainment, technology, and cannabis.

 

Heather Mahoney, President of the Haute Haus agency, will lead the Council’s digital campaign as Social Media Director through online marketing, social posting and marketing, and graphic design. Mahoney’s creative approach combined with her ability to generate and maintain brand awareness across various social media platforms positions her as a key player in CFCR’s communications strategy.

 

CFCR will also collaborate with Wild Bill, a content creation company based in Los Angeles. Wild Bill’s Creative Director Samantha Hart said she’s thrilled to have the opportunity to partner with CFCR. “As award-winning storytellers, nothing excites us more than crafting messaging that delivers results. We look forward to creating strategic materials for CFCR, and to collaborating with the team," Hart said.

 

Lead creative and graphic design communicator, Derek Friday, founder of Friday Farms Creative, built the CFCR brand voice and style while implementing a refreshed website and will assist in supplying that continuity across all channels.

 

“With BWF, Haute Haus, Wild Bill and Friday Farm, CFCR will benefit from the combined and collaborative efforts of four incredibly creative and diverse firms, all of whom are already collaborating in strategic rhythm to deliver our Council’s messaging across multiple platforms and formats,” said CFCR Executive Director Sarah Chase. “Each of these companies brings a unique yet complementary realm of expertise to our organization, and we’re seeing amazing results from this alliance. CFCR’s education, advocacy, and communication mission is being realized.” For additional information, please visit uscfcr.org.

 

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

ABOUT BWF

Brotman|Winter|Fried is a subsidiary of Sage Communications, headquartered in suburban Washington, D.C. A boutique firm in business for more than 40 years, BWF specializes in public relations, special event production and management, brand development, marketing and promotions for a broad range of clients including sports, entertainment, retail, restaurants, healthcare, cannabis, business services, trade associations, even local and federal government agencies. For additional information, please visit https://bwf.aboutsage.com. For a specific look at the company’s cannabis practice, please visit https://bwfcannabispr.com.

 

ABOUT HAUTE HAUS

Haute Haus is a strategic communications agency based in Chevy Chase, MD specializing in brand building through advertising, digital development, and publicity. HHA’s creative team believes PR lies in impactful content creation, including well-rounded social campaigns, engagement, and a strong brand narrative. Every team member hired has an extensive background in press, giving HHA a unique perspective in a diverse industry. For more information, please visit www.hautehausagency.com.

 

ABOUT WILD BILL

Wild Bill is an award-winning creative content and commercial agency specializing in authentic stories for entertainment properties, nonprofits, brands, and start-ups founded by Samantha Hart and James Lipetzky. Together, they have created content for American Express, Microsoft, Sony, and nonprofits A Better LA, A Place Called Home, Boys and Girls Club, and United Way, winning them the prestigious Gold Hugo Award. License to Operate, their feature documentary about reformed gang members in Los Angeles, debuted at SIFF and won Best Documentary Feature at the Highland International Film Festival

 

ABOUT FRIDAY FARMS

Friday Farms is a boutique, independent advertising, and creative design firm based in Washington, DC. Building brands and marketing strategies across multiple industries, including non-profits, start-ups, hospitality groups, and real estate sales firms, Friday Farms is committed to a collaborative environment to best communicate, represent, and target the desired audience no matter the industry or field.

Council for Federal Cannabis Regulation (CFCR)Launches Monthly Webinar Series to Begin
This Thursday, September 23

SEPTEMBER 17, 2021

WASHINGTON, D.C. – The Council for Federal Cannabis Regulation (CFCR) today announced the launch of a new monthly webinar series in which regulators and industry professionals will participate in moderated conversations regarding responsible cannabis regulation. CFCR’s Executive Director, Sarah A. Chase, says these webinars will explore industry best practices, while service to further the Council’s position as an industry leader for educating and advocating for forward-thinking and inclusive federal laws for the cannabis industry.

The series begins this Thursday, September 23, as CFCR launches its lineup with a virtual conversation titled Council for Federal Cannabis Regulation: Understanding the Regulatory Impact of a Groundbreaking New CBD Study. The webinar will feature Vicki Seyfert-Margolis, Chairwoman for Science & Regulatory Affairs Committee for CFCR, along with moderators Jack Jacobson from Thompson Coburn LLP and CFCR’s own Executive Director Sarah Chase.

The webinars will take place over WebEx on the second or third Thursday of every month, depending on holidays. The next event is scheduled for Thursday, October 28 and will focus on what federal regulators can learn from the states where cannabis is now legal. Each session will feature a moderator, and panelists or a fireside chat. Scheduled to begin at 1:00 p.m., EDT to run for approximately one hour, each webinar will consist of a 40-minute interactive conversation session followed by approximately 20 minutes of moderated audience Q&A.

Link to sign up and register for CFCR’s webinar series: https://www.uscfcr.org/events

 

For additional information, please visit uscfcr.org.

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

Council for Federal Cannabis Regulation Publishes Solutions-Driven Response to the Proposed Legalization Act

SEPTEMBER 8, 2021

CFCR’s Science and Regulatory Affairs Committee Provides Solutions for a Clear Pathway Forward for Federal Legalization with Published Comments to The Cannabis Administration and Opportunity Act (CAOA)

WASHINGTON, D.C. – The Council for Federal Cannabis Regulation (CFCR) today announced several key positioning statements in response to the Cannabis Administration and Opportunity Act (CAOA), recently supported and sponsored by the offices of Senators Booker, Schumer and Wyden.

Uniquely positioned as a solutions provider for both the federal government and the cannabis industry, CFCR is a non-profit organization developed to have broad and deep expertise, CFCR is informed by multifaceted perspectives, enabling it both to educate the federal agencies and the public.

 

Some of the key takeaways from CFCR’s comments include:

 

  • CFCR applauds the CAOA drafters for putting forward this discussion draft and for the transparent approach they have taken to the process. We support the fundamental approach and process. 

 

  • CFCR suggested strategies to curb bad actors, provide for interim regulations, a consortium to do safety testing (if needed), and other suggestions of how we may help to expedite the regulatory process.

 

  • CFCR’s proposed definition of cannabis does not exclude hemp, for the simple reason that cannabis and hemp are the same plant. CFCR notes that the ≤0.3% THC threshold is an arbitrary limitation that inhibits various industries and research inquiries.

 

  • CFCR suggested >1% as a threshold for High-THC cannabis. CFCR notes that as research develops other thresholds might be established, but >1% THC as the threshold for High-THC Cannabis and ≤1% THC for Low-THC Cannabis should find support at this time  

 

  • A Center for Cannabis Products as a separate entity, wherever housed, should establish a unique product standard for cannabis products. 

 

  • Cannabis products should be a separate product category for purposes of regulation and should not be shoehorned into the existing product categories, (e.g., foods and dietary supplements). 

 

  • CFCR does not support the use of GRAS and NDI for Cannabis products because Cannabis products are unique due to already being on the market and regulated at the state level. Retroactively applying NDI and GRAS to these products is not practical. More importantly the safety profile of these products is significantly different. A new Cannabis product safety standard must be developed.

 

  • In support, CFCR also suggests that the CAOA include an immediate authorization of appropriations that is sufficient to allow the FDA to staff appropriately in order to develop new and more expeditious ways to review Cannabis constituents, as well as full-spectrum or broad-spectrum products.

 

CFCR is a 40-person organization including an eight-person Science and Regulatory Affairs Committee (SRA) comprised of three PhD scientists, a world-renowned big data expert, FDA lawyers and researchers, as well as a variety of other professionals.

 

“CFCR was developed with topflight experts who can bring tools and strategies, as well as advocacy, to the federal agencies to help develop the cannabis industry safely and with all due haste,” said CFCRs Board Chair Sheri Orlowitz.

 

With its recently submitted comments (READ HERE) to the Sponsoring Offices of the Senators regarding the draft discussion of CAOA, CFCR has established itself as a unified voice for diverse industry and a trusted source of accurate science and policy guidance.

 

“Our primary focus is to work with the FDA on the regulation of cannabinoids,” said CFCR’s new Executive Director, Sarah Chase.  “CFCR’s comments to the CAOA are the product of this singular focus and we are bringing a novel solutions-driven approaches to the complex effort to federally regulate a plant that has been illegal for eight decades, with safety, fairness and efficiency.”

 

For additional information, please visit uscfcr.org.

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

Council for Federal Cannabis Regulation Introduces New Executive Director

AUGUST 30, 2021

Sarah Chase Brings 20 Years of C-Level Experience With Startups, Media Properties and Corporations to Council’s Mission to Support Federal Laws and Regulations to Govern the Cannabis Industry

WASHINGTON, D.C. -- Sheri Orlowitz, Founder and President of the Council for Federal Cannabis Regulation (CFCR), announced today the appointment of Sarah A. Chase as the organization’s first Executive Director.  A lifelong creator and business professional who has worked diligently behind the scenes at various organizations to champion both public and private projects that are mission-driven and deliver social impact, Chase brings direction, focus and motivation to the Council’s mission to educate, advocate, communicate and support the creation of informed, intelligible, and inclusive federal laws and regulations for the cannabis industry.

 

“My vision for CFCR is to ensure that we become – and will always remain -- the most trusted, and collaborative resource for the federal regulatory agencies, Congress, the White House, and the diversity of stakeholders within the cannabis industry,” Chase said. “Through our committee structure, our leadership, and our partner organizations, CFCR has been carefully structured to be the most dependable conduit through which information, knowledge, and accurate scientific information and research can be shared to ensure a safe and legal regulatory pathway. CFCR is here to help educate, to advocate, and communicate. And it is my firm belief and vision that we must always to do so with honesty, efficiency, and integrity.”

 

For nearly two decades, Chase has worked primarily with start-up companies in the media, broadcast and communication space. She has held various COO, CFO, Communication, and Business Development positions and has worked closely with executive teams in the United States, Europe and Asia to translate high-level visions into realized corporate entities.

 

From 2016 through 2020, Chase served as the Chief Operating Officer for Alan Alda’s Communication Training Company (ACT), mentoring with the legendary actor, writer and director while helping to bring his proven improv and communication methods to the world. Working closely with Alda, Chase established the first-of-its-kind public-private partnership (PPP) with the State University of New York (SUNY). The company grew from ground zero to more than $2.5M in net profit within the first two years. Because of this growth and success, Alda achieved his dream of donating the profits directly back to the Alan Alda Center for Communicating Science at Stony Brook University, to further advance the better communication of science

 

As the Executive Producer, writer, and voice-over artist for Alda’s Clear+Vivid, podcasts, Chase produced in excess of a hundred episodes generating more than 15 million downloads. The lineup included such notable guests as Tom Hanks, Paul McCartney, Julie Andrews, Madeline Albright, Tina Fey, Michael J. Fox, Judge Judy, Isabella Rossellini and others.

Chase previously led communication and media training workshops for several corporate clients as well as at the United Nations, NASA, the Nature Conservancy and various "Shark Tank" events. She has served as an executive committee member of the National Small Business Association in Washington, D.C. and was as a featured panelist and consultant with the Global Coalition for Aging at the Council on Foreign Relations.  Earlier in her career she worked in both London and Frankfurt, advising a diverse range of clients and companies. She also served as a featured political commentator on Sky News and BBC Radio. 

 

“Sarah’s expertise in the fields of communication, fundraising and business development uniquely qualifies her for this role,” said Orlowitz.  “Her passion for justice and social causes meshes perfectly with the Council’s overall mission.”

 

For additional information, please visit uscfcr.org.

####

 

ABOUT CFCR

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.  

Council for Federal Cannabis Regulation (CFCR) Congratulates its Science Co-Chair, Co-founder and Executive Chair of Radicle Science on Most Comprehensive US Trials Measuring Impact of CBD

AUGUST 24, 2021

Largest and Most Comprehensive Randomized Controlled Trial of Its Kind Helps Fill
Gap Created by Limited Real-World Evidence on Public Understanding and Use

WASHINGTON, D.C. -- According to a recent survey by data research and control management company Invisibly, nearly 60 percent of all Americans have no viable understanding of CBD. By and large, they don’t know what it stands for, what it means, nor what it does. A colloquial contraction for cannabidiol, CBD is a chemical compound found in the same plant that produces cannabis (marijuana) and hemp. Naturally occurring and fully-holistic, CBD is now widely used in oils, topicals, and ingestibles for wellness purposes and other physical and mental need states.

Through a survey of more than a thousand Americans designed to shed light on our population’s understanding of these products, 62 percent have never used any iteration of the product, and among that group, 68 percent indicated they were ignorant as to the difference between CBD and THC-infused products such as medical and recreational cannabis. Actually, that’s not surprising ... after all, there has been relatively little in the way of peer- reviewed documentation about this increasingly popular health-related supplement ... but thanks to a real-world evidence study recently launched by Radicle Science, a San Diego-based,
transformative healthtech B-corp, that’s about to change.


Earlier this month Radicle Science announced the launch of its Radicle ACES (Advancing CBD Education and Science) Study, the largest and most comprehensive randomized controlled trial of its kind, designed to capture CBD effectiveness data directly from nearly 3,000 study participants. The study has received Institutional Review Board (IRB) approval, which is generally recognized as a standard for the FDA in assuring the safety and well-being of human participants. IRB approvals are currently rare among the industry, and this further demonstrates the high-standards of this scientific study.


During the four-week trial period, scheduled to conclude in late September, participants will track consumption and effectiveness of orally-ingested CBD products from 13 major U.S. CBD brands, focusing on well-being, quality of life, and other common physical and mental need states. Radicle ACES will use validated, standardized health indices to gather health outcome data from a diverse population across a variety of ethnicities, age groups, geographies, behavioral habits, and pre-existing health conditions. The real-world evidence collected will inform scientific understanding on usage patterns, user characteristics, effectiveness across conditions, and predictors and modifiers of response. And quite frankly, the leadership at the Council for Federal Cannabis Regulations (CFCR)
could not be happier.

“This study represents sound, accurate, and responsible scientific research, which continues to create intelligible and inclusive pathways for CBD products,” said Council Founder Sheri L. Orlowitz, whose organization’s primary goal is to interface with the FDA on how to proceed with cannabis safety testing, research, and regulation on behalf of currently existing and future cannabis producers. “Studies of this magnitude are needed in order to put public health and safety first and foremost, as the entire cannabis industry is faced with federal regulation and the need for data, science and expertise. CFCR recognizes that further understanding and dialogue is needed to better align cannabis industry policy, scientific research and data, and regulatory measures. Our mission is to help bridge that gap not only through advocacy, education, and clear-cut communication but also by sharing knowledge and expertise from our international partners around the world and our eight-person science team with four PhDs." 

According to Radicle’s founding team, this study will achieve precisely that. “A rigorous scientific study of this magnitude has never before been conducted in the CBD market,” said Pelin Thorogood, Co-founder and Executive Chair of Radicle Science. “Radicle ACES is driven by our deep commitment to contribute to the body of evidence to support growing demand from consumers and healthcare providers.


“Given the scale, the diversity of the participant population and the wide range of high-quality commercial brands included, Radicle ACES promises to deliver rich, objective health outcome data for a variety of common health-related complaints, with the potential to offer unprecedented guidance on CBD effectiveness based on demographic or behavioral differences.” As Co-Chair of the Science and Regulatory Affairs Committee (SRA) for CFCR, Thorogood brings this perspective and expertise to the CFCR team.


The brands being tested in the study are fully supportive of this research. According to a quote from Dr. Kenton Crowley, Director of Research and Development who is overseeing the production of Trokie, one of the 13 brands integrated into the study, “the collaboration between Radicle Science, academic medicine and therapeutically-focused cannabinoid brands makes this trial particularly exciting. We are thrilled to be a part of a rigorous investigation into how Trokie and other clinically relevant CBD products can improve the lives of consumers and also hopefully expand the avenues for more clinical cannabinoid research.” The other brands included in the trial include ALTWELL, Charlotte’s Web, Columbia Care, Healer, Lord Jones, Maven Hemp, MD FARMA, Peels, Prospect Farms, PURAURA Naturals from Enhanced Botanicals, Rae Wellness and Verséa Wellness.

 

For additional information, please visit uscfcr.org.

 

####

 

ABOUT CFCR
The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.

 

ABOUT RADICLE SCIENCE
Radicle Science is a transformative healthtech B-corp offering the first-ever path to natural product validation at scale. Radicle Science disrupts the traditional clinical trial model by combining the reach of a market research company, the scientific rigor of a research university, and the agility of a tech company. Operating at the intersection of big data, digital health and natural products, Radicle Science leverages a proprietary data analytics platform and a virtual, direct-to-consumer (D2C) model to deliver objective health outcome data across diverse populations and conditions. Our Radicle Vision is a future where affordable, accessible, natural health products are trusted by patients, recommended by healthcare providers, reimbursed by insurance, and used as widely as pharmaceutical drugs. To learn more, please visit www.radiclescience.com and follow their LinkedIn page.

Council for Federal Cannabis Regulation (CFCR)Ramps Up Mission Activity through Series of Events

And Engagement of New Key Personnel

AUGUST 18, 2021

WASHINGTON, D.C. -- The Council for Federal Cannabis Regulation (CFCR) launched last year as an umbrella organization designed to advocate for federal regulations to enhance public faith and trust in cannabis-infused products as the industry continues to approach full nationwide legalization. 

 

CFCR’s initial mission is to work with federal agencies, including the U.S. Food & Drug Administration and even the White House to develop a safe “legal” harbor for all non-THC products in the marketplace today, and to expedite the development of a legal regulatory pathway. The organization has quietly attracted top talent for this initial mission, including four PhD’s, and has largely flown under the radar awaiting a new FDA Commissioner to begin its critical work.

 

According to Council Founder Sheri L. Orlowitz, CFCR’s “quiet approach” to this point is about to change.

 

Through the appointment of a new executive director and the engagement of a powerful team of industry and federal government professionals – ranging from scientists and C-Level corporate executives to attorneys, financial experts and cannabis industry specialists – the non-profit Council is now poised to embark on its core mission objectives: namely to represent the interests of the current and future industry stakeholders as cannabis continues to face increased regulation by various federal agencies.

 

“CFCR was designed to provide tools, business guidance and scientific resources to support the FDA’s process to regulate cannabis compounds; to attract and educate established industry and encourage its support and investment in the regulatory process and to ensure regulations are informed by and grounded in the policies behind legalization such as access to cannabis without undue burden and restorative justice,” said Orlowitz, a former Department of Justice Prosecutor who is also a Founding Partner of Artemis Holdings, a Board Member of the Marijuana Policy Project and a Founding Member of the US Cannabis Council.  “These objectives will be achieved by a series of programs CFCR will facilitate, designed to inform and support FDA safety requirements, developing an agreed path for cannabis, building off accurate science, extensive research studies and best practices from other countries and educating and attracting hesitant stakeholders and encouraging them to invest in regulation.”

 

The FDA, Orlowitz says, ultimately holds the key to the eventual widespread acceptance and integration of cannabis-related product into the marketplace. 

 

“In addition to medical-use cannabis, the huge demand for CBD is not being met because producers are operating under a fog of regulatory uncertainty, and consumers do not know which are trusted products. The CFCR will work with consumer-packaged goods and cannabis company stakeholders to explore and recommend a pathway for FDA approval of cannabis-infused products as a dietary supplement and food additive.”

 

 

CFCR was created as a “think and do” tank to serve as a forum in which stakeholders – both from the federal government and industry – will analyze and support the creation of informed federal laws and regulations to safely govern the cannabis industry without being unduly burdensome. The Council is composed of four committees: a Scientific and Regulatory Affairs Committee, a Corporate and Business Committee, a Legal and Government Relations Committee and a DEI Committee, each led by best-in-class experts in their respective fields.

 

For additional information, please visit uscfcr.org.

 

####

 

ABOUT CFCR

 

The Council for Federal Cannabis Regulation (CFCR) is 501(c)(3) and 501(c)(4) non-profit that serves as a forum in which stakeholders -- both from the federal government and industry -- can analyze and support the creation of informed, intelligible, and inclusive federal laws and regulations to govern the cannabis industry. CFCR exists to educate, advocate, and communicate. For additional information please visit www.uscfcr.org and follow us on social media @USCFCR.